Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome

Expression of type 5 phosphodiesterase (PDE5), a cGMP-specific hydrolytic enzyme, is frequently altered in human cancer, but its specific role in tumorigenesis remains controversial. Herein, by analyzing a cohort of 69 patients affected by glioblastoma multiforme (GBM) who underwent chemo- and radio...

Descripción completa

Detalles Bibliográficos
Autores principales: Cesarini, Valeriana, Martini, Maurizio, Vitiani, Lucia Ricci, Gravina, Giovanni Luca, Agostino, Silvia Di, Graziani, Grazia, D'Alessandris, Quintino Giorgio, Pallini, Roberto, Larocca, Luigi M, Rossi, Pellegrino, Jannini, Emmanuele A, Dolci, Susanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355091/
https://www.ncbi.nlm.nih.gov/pubmed/28099939
http://dx.doi.org/10.18632/oncotarget.14656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355091/
https://www.ncbi.nlm.nih.gov/pubmed/28099939
http://dx.doi.org/10.18632/oncotarget.14656

Ejemplares similares